The global butterfly needle blood collection set market was $166.60 million in 2019, and is expected to reach $320.02 million by 2027, registering a CAGR 8.20% from 2020 to 2027.

A butterfly needle is a device used to provide access to superficial vein for drawing blood or for an IV injection. These needles are much easier to use and is less painful due to winged tubing structure that allows greater flexibility. In addition, butterfly needles, also known as a winged infusion set or a scalp vein set, are commonly used for babies, young children, and elderly to draw blood or to administer medication. The needles are short and straight with plastic wings attached for phlebotomists to hold during insertion and ease operation. In addition, winged-infusion blood collection needles are ideal for individuals with small or fragile veins. Further, the common butterfly needles, which are frequently used ranges from gauges, with 21 and 23 gauge (G) and the smallest gauge i.e., 25-27G, are being used primarily for pediatric patients.

The major factors that drive the market growth are rise in prevalence of chronic diseases globally such as cancer, intravenous therapy, cardiovascular diseases, and bleeding disorders. In addition, increase in prevalence of chronic diseases and need for managing long term medications and drug infusions are some of the other factors that boost the growth of the market. However, lack of product innovations and regulatory standards on butterfly needle usage and phlebotomists blood collection hamper the market growth. Moreover, safety and convenience provided by the needles d treatment associated with butterfly needle offer opportunities for the market growth during the forecast period.

The global butterfly needle blood collection set market is segmented on the basis of application, end user, and region. By application, the market is segmented into blood transfusion, venipuncture, IV rehydration, and delivery of medications. By end user, it is segmented into hospitals, blood bank, and others. Region wise, the market is categorized into North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries.

KEY BENEFITS FOR STAKEHOLDERS

- The market estimations in this report are based on high-end analysis of the key segments from 2019 to 2027.
- Extensive analysis of the global butterfly needle blood collection set market, by application, helps in understanding various types of techniques of butterfly needles.
- This report provides comprehensive analysis of factors that drive and restrict growth of the butterfly needle blood collection set market.
- Porter's Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants, substitutes, and competition among the key market players.
- Competitive intelligence highlights the business practices adopted by leading market players across various regions.

Key Market Segments

- By application
o Blood transfusion
o Venipuncture
o IV rehydration
o Delivery of medications
- By end user
o Hospitals
o Blood banks
o Others
- By Region
o North America
- U.S.
- Canada
- Mexico
o Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
o Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
o LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Rest of LAMEA

List of key players profiled in the report

- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Nipro Corporation
- Cardinal Health, Inc.
- Medline Industries, Inc.
- Terumo Corporation
- Kawasumi Laboratories, Inc.
- ISOMed
- BioMatrix S.r.l